We are live on ! Find out more
MKA

M. Kulyk & Associates Portfolio holdings

AUM $536M
1-Year Est. Return 18.28%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+18.28%
3 Year Est. Return
+52.28%
5 Year Est. Return
+66.13%
10 Year Est. Return
AUM
$299M
AUM Growth
+$11.8M
Cap. Flow
-$12.8M
Cap. Flow %
-4.28%
Top 10 Hldgs %
38.15%
Holding
104
New
4
Increased
66
Reduced
17
Closed
3

Top Sells

Rank Stock Value
1
LEVI icon
Levi Strauss
LEVI
+$18.6M
2
TSLA icon
Tesla
TSLA
+$670K
3
LLY icon
Eli Lilly
LLY
+$313K
4
HSY icon
Hershey
HSY
+$246K
5
IBM icon
IBM
IBM
+$233K

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Healthcare 11.66%
3 Financials 11.06%
4 Consumer Staples 10.68%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAG icon
51
STAG Industrial
STAG
$7.1B
$1.72M 0.57%
53,145
+1,095
+2% +$34.3K
CEG icon
52
Constellation Energy
CEG
$93.2B
$1.62M 0.54%
18,839
-173
-0.9% -$15.6K
ESGV icon
53
Vanguard ESG US Stock ETF
ESGV
$13.5B
$1.49M 0.5%
22,551
-499
-2% -$33.3K
BEPC icon
54
Brookfield Renewable
BEPC
$6.19B
$1.48M 0.49%
53,670
+2,045
+4% +$63.2K
DVY icon
55
iShares Select Dividend ETF
DVY
$23.5B
$1.08M 0.36%
8,972
+1
+0% +$118
IWF icon
56
iShares Russell 1000 Growth ETF
IWF
$127B
$1.04M 0.35%
19,492
-424
-2% -$23.3K
LEVI icon
57
Levi Strauss
LEVI
$9.35B
$955K 0.32%
61,524
-1,195,475
-95% -$18.6M
AMP icon
58
Ameriprise Financial
AMP
$49.5B
$910K 0.3%
2,922
MPT
59
Medical Properties Trust
MPT
$2.75B
$843K 0.28%
75,657
+3,856
+5% +$44.8K
ABBV icon
60
AbbVie
ABBV
$431B
$832K 0.28%
5,147
+75
+1% +$11.5K
PEP icon
61
PepsiCo
PEP
$189B
$778K 0.26%
4,308
+48
+1% +$8.56K
JNJ icon
62
Johnson & Johnson
JNJ
$619B
$707K 0.24%
4,005
+851
+27% +$147K
GOOG icon
63
Alphabet (Google) Class C
GOOG
$4.36T
$625K 0.21%
7,040
HEDJ icon
64
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
$605K 0.2%
17,306
+1,216
+8% +$42.2K
KRBN icon
65
KraneShares Global Carbon Strategy ETF
KRBN
$142M
$535K 0.18%
14,666
+394
+3% +$16.6K
SBUX icon
66
Starbucks
SBUX
$120B
$511K 0.17%
5,153
-500
-9% -$47.2K
LOW icon
67
Lowe's Companies
LOW
$122B
$500K 0.17%
2,511
-12
-0.5% -$2.4K
ABT icon
68
Abbott
ABT
$187B
$494K 0.17%
4,504
+300
+7% +$31.1K
WAB icon
69
Wabtec
WAB
$49.9B
$462K 0.15%
4,624
BRK.B icon
70
Berkshire Hathaway Class B
BRK.B
$1.13T
$457K 0.15%
1,480
+50
+3% +$14.8K
AMZN icon
71
Amazon
AMZN
$2.94T
$401K 0.13%
4,773
+24
+0.5% +$2.37K
MMM icon
72
3M
MMM
$93.2B
$399K 0.13%
3,981
+230
+6% +$23.5K
PFE icon
73
Pfizer
PFE
$149B
$399K 0.13%
7,779
+284
+4% +$13.6K
SPTS icon
74
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.11B
$353K 0.12%
12,209
-2,782
-19% -$80.4K
VYM icon
75
Vanguard High Dividend Yield ETF
VYM
$82.3B
$346K 0.12%
3,194
-750
-19% -$79.8K

Similar funds

M. Kulyk & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, M. Kulyk & Associates held 104 positions worth $299M, up 4.1% from $288M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

M. Kulyk & Associates withdrew a net $12.8M in Q4 2022, closing 3 positions and reducing 17 holdings. Its most notable exit was Tesla, an estimated $670K position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, M. Kulyk & Associates opened a new position in Deere & Co worth $252K.

  • M. Kulyk & Associates's largest Q4 2022 buy was Deere & Co: 587 shares worth $252K.
  • M. Kulyk & Associates added most to iShares 0-5 Year TIPS Bond ETF in Q4 2022, an estimated $1.52M increase.
  • M. Kulyk & Associates's biggest Q4 2022 reduction was Levi Strauss, cutting an estimated $18.6M.
  • M. Kulyk & Associates fully exited Tesla in Q4 2022, selling an estimated $670K.
  • M. Kulyk & Associates's ten largest holdings make up 38% of its $299M portfolio in Q4 2022.
  • M. Kulyk & Associates opened 4 new positions and closed 3 in Q4 2022.
  • M. Kulyk & Associates's portfolio value rose 4.1% quarter-over-quarter to $299M.

Based on M. Kulyk & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.